|
|
Volumn 103, Issue , 2000, Pages 137-155
|
|
Preoperative chemotherapy for operable breast cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR MARKER;
ADJUVANT CHEMOTHERAPY;
BREAST TUMOR;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
FEMALE;
FORECASTING;
HUMAN;
MAMMOGRAPHY;
MASTECTOMY;
METHODOLOGY;
MORTALITY;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
POSTMENOPAUSE;
PREMEDICATION;
PREMENOPAUSE;
PROGNOSIS;
RADIOGRAPHY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SEGMENTAL MASTECTOMY;
SURGICAL INSTRUMENT;
SURVIVAL RATE;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
FEMALE;
FORECASTING;
HUMANS;
MAMMOGRAPHY;
MASTECTOMY;
MASTECTOMY, SEGMENTAL;
MULTICENTER STUDIES;
POSTMENOPAUSE;
PREMEDICATION;
PREMENOPAUSE;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
SURGICAL INSTRUMENTS;
SURVIVAL RATE;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
MLCS;
MLOWN;
|
|
EID: 0033657313
PISSN: 09273042
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-4757-3147-7_7 Document Type: Review |
|
Times cited : (9)
|
|
References (30)
|
